---
schema_version: "secwatch.filing_event.v1"
accession: "0001612630-24-000003"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:33:09.237681+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q1 rev $29.7M (+5% YoY), operating income $1.1M, reiterates guidance

## Summary
- Revenue $29.7M (+5% YoY); operating income $1.1M vs loss $653k; net income $0.06/diluted share.
- Adjusted EBITDA $3.5M (+75% from $2.0M); system-wide comp sales +3%.
- Opened 23 franchised clinics; total clinic count 954; sold 15 franchise licenses, triple Q4 2023's 5.
- FY 2024 guidance reiterated: system-wide sales $530-545M, new franchised openings 60-75 (excl. refranchising).
- Hired investment bank specializing in refranchising to accelerate corporate clinic portfolio transition.

## SEC filing metadata
- accession: 0001612630-24-000003
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/jynt-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001612630-24-000003
- JSON: https://secwatch.observer/filing/0001612630-24-000003.json
- Plain text: https://secwatch.observer/filing/0001612630-24-000003.txt

## Key facts
- Earnings Releases
  JOINT Corp reported Q1 2024 results: revenue $29.7 million, net income $947,000, EPS $0.06 per diluted share. Guidance reaffirmed.
  - Period: Q1 2024
  - Revenue: $29.7 million
  - Net income: $947,000
  - EPS: $0.06 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 5% to $29.7 million. • Recorded operating income of $1.1 million, compared to operating loss of $653,000. • Reported net income of $947,000, compared to $2.3 million, including the receipt of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.